(XMLV) S&P MidCap Low Volatility - Overview
Etf: ETF, MidCap, Low Volatility, S&P 400
Dividends
| Dividend Yield | 2.89% |
| Yield on Cost 5y | 3.97% |
| Yield CAGR 5y | 28.14% |
| Payout Consistency | 95.7% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 12.1% |
| Relative Tail Risk | 0.05% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.44 |
| Alpha | -0.49 |
| Character TTM | |
|---|---|
| Beta | 0.493 |
| Beta Downside | 0.499 |
| Drawdowns 3y | |
|---|---|
| Max DD | 13.83% |
| CAGR/Max DD | 0.63 |
Description: XMLV S&P MidCap Low Volatility January 25, 2026
The Invesco S&P MidCap Low Volatility ETF (XMLV) seeks to track an index that selects roughly 80 of the least-volatile stocks from the S&P MidCap 400, requiring the fund to hold at least 90 % of its assets in those securities.
As of the most recent filing (12 Feb 2026), XMLV reported a net expense ratio of 0.18 %, total assets of about $1.9 bn, and a 30-day SEC-based volatility of 13.2 %-roughly 30 % lower than the broader S&P MidCap 400. The top five holdings (as of 31 Jan 2026) were Corteva (1.8 %), Aflac (1.6 %), Lennar (1.5 %), CME Group (1.4 %) and Parker-Hannifin (1.3 %). The portfolio is weighted toward defensive sectors: Consumer Staples (22 %), Health Care (20 %) and Utilities (15 %), which historically benefit from slower-growth, inflation-resilient environments.
Given the ETF’s focus on low-volatility mid-cap equities, its performance is especially sensitive to the business-cycle phase and monetary-policy stance; a prolonged tightening cycle could compress earnings growth for many mid-caps, while a shift to a more accommodative policy could boost the sector’s relative attractiveness.
For a deeper, data-driven assessment of XMLV’s risk-adjusted returns and how it fits into a diversified portfolio, you might explore the analytical tools on ValueRay.
What is the price of XMLV shares?
Over the past week, the price has changed by +3.29%, over one month by +3.90%, over three months by +5.68% and over the past year by +10.80%.
Is XMLV a buy, sell or hold?
What are the forecasts/targets for the XMLV price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 73.1 | 10.7% |
XMLV Fundamental Data Overview February 09, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 756.6m USD (756.6m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 756.6m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 756.6m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 7.73% (E(756.6m)/V(756.6m) * Re(7.73%) + (debt-free company))
Discount Rate = 7.73% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)